Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Lam

Showing results (421-430 of 743) with videos related to

Pageof 75
Sort By:
Molecular Cancer Therapeutics|April 27, 2011
ATM and p53 regulate FOXM1 expression via E2F in breast cancer epirubicin treatment and resistanceJulie Millour, Natalia de Olano, Yoshiya Horimoto, et al.
Cancers|March 1, 2020
A Splice Variant of NCOR2, BQ323636.1, Confers Chemoresistance in Breast Cancer by Altering the Activity of NRF2Man-Hong Leung, Ho Tsoi, Chun Gong, et al.
Scientific Reports|February 8, 2019
FOXM1 modulates 5-FU resistance in colorectal cancer through regulating TYMS expressionVidhya Varghese, Luca Magnani, Narumi Harada-Shoji, et al.
Oncogenesis|March 16, 2018
SUMOylation modulates FOXK2-mediated paclitaxel sensitivity in breast cancer cellsGabriela Nestal de Moraes, Zongling Ji, Lavender Y-N Fan, et al.
Eye (London, England)|March 11, 2008
Surgically induced astigmatism in phacoemulsification, pars plana vitrectomy, and combined phacoemulsification and vitrectomy: a comparative studyC Y F Yuen, B T O Cheung, C-W Tsang, et al.
International Journal for Parasitology|January 28, 2023
Drug susceptibility testing for oxygen-dependent and oxygen-independent resistance phenotypes in trichomonadsAlexander Y F Lam, Ernest Lacey, Vesna De Petra, et al.
Molecular Cancer Therapeutics|March 2, 2026
Expression of Concern: ATM and p53 Regulate FOXM1 Expression via E2F in Breast Cancer Epirubicin Treatment and ResistanceJulie Millour, Natalia de Olano, Yoshiya Horimoto, et al.
AEM Education and Training|December 13, 2021
Design of a point-of-care ultrasound curriculum for pediatric emergency medicine fellows: A Delphi studyDelia Gold, Marla Levine, Deborah Hsu, et al.
Oncogene|July 18, 2019
Regulation of PERK expression by FOXO3: a vulnerability of drug-resistant cancer cellsGlowi Alasiri, Yannasittha Jiramongkol, Stefania Zona, et al.
Molecular Carcinogenesis|April 11, 2016
Exogenous FABP4 increases breast cancer cell proliferation and activates the expression of fatty acid transport proteinsSandra Guaita-Esteruelas, Alba Bosquet, Paula Saavedra, et al.
Pageof 75

Showing results (421-430 of 743) with videos related to

Sort By:
Pageof 75
Molecular Cancer Therapeutics|April 27, 2011
ATM and p53 regulate FOXM1 expression via E2F in breast cancer epirubicin treatment and resistanceJulie Millour, Natalia de Olano, Yoshiya Horimoto, et al.
Cancers|March 1, 2020
A Splice Variant of NCOR2, BQ323636.1, Confers Chemoresistance in Breast Cancer by Altering the Activity of NRF2Man-Hong Leung, Ho Tsoi, Chun Gong, et al.
Scientific Reports|February 8, 2019
FOXM1 modulates 5-FU resistance in colorectal cancer through regulating TYMS expressionVidhya Varghese, Luca Magnani, Narumi Harada-Shoji, et al.
Oncogenesis|March 16, 2018
SUMOylation modulates FOXK2-mediated paclitaxel sensitivity in breast cancer cellsGabriela Nestal de Moraes, Zongling Ji, Lavender Y-N Fan, et al.
Eye (London, England)|March 11, 2008
Surgically induced astigmatism in phacoemulsification, pars plana vitrectomy, and combined phacoemulsification and vitrectomy: a comparative studyC Y F Yuen, B T O Cheung, C-W Tsang, et al.
International Journal for Parasitology|January 28, 2023
Drug susceptibility testing for oxygen-dependent and oxygen-independent resistance phenotypes in trichomonadsAlexander Y F Lam, Ernest Lacey, Vesna De Petra, et al.
Molecular Cancer Therapeutics|March 2, 2026
Expression of Concern: ATM and p53 Regulate FOXM1 Expression via E2F in Breast Cancer Epirubicin Treatment and ResistanceJulie Millour, Natalia de Olano, Yoshiya Horimoto, et al.
AEM Education and Training|December 13, 2021
Design of a point-of-care ultrasound curriculum for pediatric emergency medicine fellows: A Delphi studyDelia Gold, Marla Levine, Deborah Hsu, et al.
Oncogene|July 18, 2019
Regulation of PERK expression by FOXO3: a vulnerability of drug-resistant cancer cellsGlowi Alasiri, Yannasittha Jiramongkol, Stefania Zona, et al.
Molecular Carcinogenesis|April 11, 2016
Exogenous FABP4 increases breast cancer cell proliferation and activates the expression of fatty acid transport proteinsSandra Guaita-Esteruelas, Alba Bosquet, Paula Saavedra, et al.
Pageof 75